Selected Publications:
Jose Torres, Amy Pruitt, Laura Balcer, Steven Galetta, Clyde Markowitz, Nabila Dahodwala: Analysis of the treatment of neuromyelitis optica Journal of the Neurological Sciences 351 (1): 2015.
Salim Chahin, Deborah Miller, Reiko E. Sakai, James A. Wilson, Teresa Frohman, Clyde Markowitz, Dina Jacobs, Ari Green, Peter A. Calabresi, Elliot M. Frohman, Steven L. Galetta, Laura J. Balcer: Relation of quantitative Visual and neurologic outcomes to fatigue in multiple sclerosis Multiple Sclerosis and Related Disorders 4 (4): 2015.
Edward Fox, Barbara Green, Clyde Markowitz, Ronald Murray, Andrew D Goodman, Stephen J Glenski, Pippa Loupe, Jo Nita Cogburn: The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis BMC Neurology 14 (1): 2014.
Patricia K Coyle, Bruce A Cohen, Thomas Leist, Clyde Markowitz, Merrikay Oleen-Burkey, Marc Schwartz, Mark J Tullman, Howard Zwibel: Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes BMC Neurology 14 (1): 2014.
Miller Aaron E, Cohen Bruce A, Krieger Stephen C, Markowitz Clyde E, Mattson David H, Tselentis Helen N: Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple sclerosis (Houndmills, Basingstoke, England) : 2013.
Oh Se-Hong, Bilello Michel, Schindler Matthew, Markowitz Clyde E, Detre John A, Lee Jongho: Direct visualization of short transverse relaxation time component (ViSTa). NeuroImage 83C : 485-492,2013.
Fox Edward, Wynn Daniel, Cohan Stanley, Rill Donna, McGuire Dawn, Markowitz Clyde: A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design. Multiple sclerosis (Houndmills, Basingstoke, England) 18 (6): 843-52,2012.
Dhib-Jalbut S, Markowitz C, Patel P, Boateng F, Rametta M: The Combined Effect of Nursing Support and Adverse Event Mitigation on Adherence to Interferon Beta-1b Therapy in Early Multiple Sclerosis International Journal of MS Care 14 (4): 198-208,2012.
Schelleman Hedi, Pollard John R, Newcomb Craig, Markowitz Clyde E, Bilker Warren B, Leonard Mary B, Hennessy Sean: Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures. Pharmacoepidemiology and drug safety 20 (6): 619-25,2011.
Keltner JL, Cello KE, Balcer LJ, Calabresi PA, Markowitz CE, Werner JS: Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials Neuro-Ophthalmology 35 (2): 57-64,2011.